Cardiovascular Disease and Type 2 Diabetes Are Costly Comorbidities
Cardiovascular (CV) disease and type 2 diabetes (T2D) commonly co-occur and contribute to the high cost of treatment.1
The Burden of CV Disease in T2D
CV disease accounts for 28% of the cost of treating type 2 diabetes and its complications2,*
Evaluate the health system population to control costs
Deeper insights into the population of patients with T2D and CV disease can help identify and manage the costs of providing treatment. Begin by evaluating the:
Total number of adult patients
Total CV readmissions and costs
Total CV admissions and costs
Potential cost savings by % reduction in CV events
Learn about how UPMC Health Plan leveraged value-based care models to improve patient health and reduce the total cost of care for adult patients with T2D and established CV disease
You are now leaving Strategies for Quality Care
Products and Support Programs from Boehringer Ingelheim